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ABSTRACT: In this work a photosubstitution strategy is presented that can be
used for the isolation of chiral organometallic complexes. A series of five
cyclometalated complexes Ru(phbpy)(N−N)(DMSO-κS)](PF6) ([1]PF6-
[5]PF6) were synthesized and characterized, where Hphbpy = 6′-phenyl-2,2′-
bipyridyl, and N−N = bpy (2,2′-bipyridine), phen (1,10-phenanthroline), dpq
(pyrazino[2,3-f ][1,10]phenanthroline), dppz (dipyrido[3,2-a:2′,3′-c]phenazine,
or dppn (benzo[i]dipyrido[3,2-a,2′,3′-c]phenazine), respectively. Due to the
asymmetry of the cyclometalated phbpy− ligand, the corresponding [Ru-
(phbpy)(N−N)(DMSO-κS)]+complexes are chiral. The exceptional thermal
inertness of the Ru−S bond made chiral resolution of these complexes by
thermal ligand exchange impossible. However, photosubstitution by visible light
irradiation in acetonitrile was possible for three of the five complexes ([1]PF6-
[3]PF6). Further thermal coordination of the chiral sulfoxide (R)-methyl p-
tolylsulfoxide to the photoproduct [Ru(phbpy)(phen)(NCMe)]PF6, followed by reverse phase HPLC, led to the separation
and characterization of the two diastereoisomers of [Ru(phbpy)(phen)(MeSO(C7H7))]PF6, thus providing a new
photochemical approach toward the synthesis of chiral cyclometalated ruthenium(II) complexes. Full photochemical,
electrochemical, and frontier orbital characterization of the cyclometalated complexes [1]PF6-[5]PF6 was performed to explain
why [4]PF6 and [5]PF6 are photochemically inert while [1]PF6-[3]PF6 perform selective photosubstitution.
■ INTRODUCTION
Since the clinical approval of cisplatin a great number of
inorganic complexes with anticancer properties have been
described, among which several ruthenium complexes have
reached clinical trials. Currently, most research is focused on
either compounds based upon the piano-stool Ru(II)η6-arene
scaffold pioneered by the groups of Dyson and Sadler1,2 or
ruthenium(II) polypyridyl complexes, of which several (photo-
active) candidates have been developed by the groups of
Dunbar,3 Gasser,4 Glazer,5 Renfrew,6 Keyes,7,8 Kodanko,9,10 or
Turro.11 More recently cyclometalated analogues of these
complexes have emerged as a new subclass of light-activatable
anticancer complexes.3,12,13 In this type of compounds, one
nitrogen atom in a polypyridyl ligand has been replaced by a
carbon atom, resulting in an organometallic metallacycle.14−17
As a consequence, cyclometalated compounds often show
enhanced properties for chemotherapy or photodynamic
therapy (PDT) than their noncyclometalated analogons.14 In
particular, the lower charge of cyclometalated complexes leads
to an increased lipophilicity, which in turn increases uptake in
cancer cells18 and often leads to higher cytotoxicity19 toward
cancer cells. In addition, cycloruthenated polypyridyl com-
plexes have increased absorption in the red region of the
spectrum, which is excellent for photochemotherapy. Whereas
polypyridyl ruthenium complexes typically absorb between 400
and 600 nm,20 a bathochromic shift is usually observed for
cyclometalated compounds due to the destabilization of t2g
orbitals by the π-donating cyclometalated carbanionic ligand,
potentially allowing activation of these compounds in the
photodynamic window, (600−1000 nm) where light pene-
trates further into biological tissue.21 Although cyclometalation
often leads to a significant decrease of the photosubstitution
properties of ruthenium complexes, the group of Turro has
reported two cyclometalated complexes, cis-[Ru(phpy)(phen)-
(MeCN)2]PF6 and cis-[Ru(phpy)(bpy)(MeCN)2]PF6, (phpy
= 2-phenylpyridine), that are capable of exchanging their
acetonitrile ligand upon light irradiation and are phototoxic in
cancer cells.22
Inspired by this work and following our investigation of
caged ruthenium complexes with the general formula [Ru-
(tpy)(N−N)(L)]2+ in which L is a sulfur-based ligand and tpy
= 2,2′;6′,2″-terpyridine, we herein investigated the preparation
and properties of cycometalated analogues of this family of
complexes where the carbanion is introduced in the tridentate
ligand. Five complexes [1]PF6−[5]PF6 with the general
formula [Ru(phbpy)(N−N)(DMSO-κS)]PF6 with Hphbpy =
6′-phenyl-2,2′-bipyridyl and N−N = bpy (2,2′-bipyridine,
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[1]PF6), phen (1,10-phenanthroline, [2]PF6), dpq (pyrazino-
[2,3-f ][1,10]phenanthroline, [3]PF6), dppz (dipyrido[3,2-
a:2′,3′-c]phenazine), [4]PF6), and dppn (benzo[i]dipyrido-
[3,2-a:2′,3′-c]phenazine, [5]PF6), respectively, were consid-
ered. Interestingly, by replacing one of the lateral nitrogen
atoms of terpyridine in [Ru(tpy)(N−N)(L)]2+ by a carbon
ligand, these ruthenium complexes become chiral, and using
chiral monodentate sulfoxides should allow for separating their
diastereomers.23−25 However, these cyclometalated complexes
turned out to be substitutionally inert under thermal
conditions, preventing displacement of DMSO in the racemic
precursor. In order to achieve the resolution of [1]PF6, it was
therefore necessary to design a photochemical route. By
investigating the photophysical properties and photoreactivity
of these complexes, three of these complexes were found
suitable for this approach, of which one was resolved using a
chiral monodentate sulfoxide ligand.
■ RESULTS
Synthesis and Crystal Structures. The first attempted
route toward the synthesis of compounds [1]PF6−[5]PF6
(Figure 1), inspired by the report of Ryabov and co-workers,26
consisted of the coordination of the terpyridine analogon
Hphbpy to the ruthenium benzene dimer [(η6-C6H6)RuCl(μ-
Cl)]2. However, this approach afforded the intermediate
species [Ru(phbpy)(MeCN)3]PF6 in a maximum yield of
only 32% and proved to be difficult to scale up. Therefore, an
alternative route depicted in Scheme 1 was developed. Starting
from cis-[RuCl2(DMSO-κS)3(DMSO-κO)], the reaction of the
bidentate ligand N−N = bpy, phen, dpq, dppz, or dppn was
realized first, followed by cyclometalation using Hphbpy in the
presence of a catalytic amount of N-methylmorpholine,
affording the five compounds [Ru(phbpy)(N−N)(DMSO-
κS)]PF6 ([1]PF6−[5]PF6) as a racemic mixture of enan-
tiomers in good yield (65−74%).
Single crystals suitable for X-ray structure determination
were obtained by slow vapor diffusion of ethyl acetate in
dichloromethane for [1]PF6, hexane in dichloromethane for
[2]PF6 and [3]PF6, and toluene in DCM for [4]PF6. All
compounds crystallized in space groups having an inversion
center, thus containing a (1:1) mixture of enantiomers. A
selection of bond lengths and angles is shown in Table 1. As
expected, the ruthenium centers in these compounds have a
distorted octahedral geometry similar to that of their terpyridyl
analogues.27 Compared to [Ru(tpy)(bpy)(DMSO-κS)](OTf)2
replacing the nitrogen within this scaffold with an anionic
carbon atom has only a modest effect on the corresponding
bond length, with Ru1−C1 in [1]PF6 (2.043(2) Å) being
almost as long as Ru1−N1 in its terpyridine analogue (2.079
Å).28 Furthermore, compared to its noncyclometalated
analogon the trans-influence of the carbon atom in phbpy−
results in an elongation of the Ru1−N2 bond length in
[Ru(phbpy)(bpy)(DMSO-κS)]2+ (2.173(2) Å), whereas in
[Ru(tpy)(bpy)(DMSO-κS)]2+ the Ru1−N3 length is 2.073(3)
Å.29 In contrast, the ruthenium−sulfur bond length is shorter
Figure 1. Chemical structures of the complexes presented in this
study. [Ru(phbpy)(N−N)(DMSO-κS)]+, where N-N = bpy, phen,
dpq, dppz, or dppn.
Scheme 1. Reagents and Conditionsa
a(a) N−N = bpy in EtOH/DMSO (15:1), reflux, 86%; (b) HPhbpy, cat. N-methylmorpholine in MeOH/H2O (5:1), reflux, 65%. For N−N =
phen = 77% and 68%, N−N = dpq = 95% and 74%, N−N = dppz = 87% and 73%, NN = dppn = 96% and 65%.
Table 1. Selected Bond Distances (Å) and Bond Angles
(deg) for Complexes [1]PF6, [2]PF6, [3]PF6, and [4]PF6.
[1]PF6 [2]PF6 [3]PF6 [4]PF6
Ru1−S1 2.2558(7) 2.2359(4) 2.2405(9) 2.210(3)
Ru1−C1 2.043(2) 2.041(3) 2.029(5) 2.030(1)
Ru1−N1 2.002(2) 2.004(2) 2.005(5) 2.019(7)
Ru1−N2 2.173(2) 2.164(2) 2.176(3) 2.180(1)
Ru1−N3 2.088(2) 2.110(2) 2.089(3) 2.094(3)
Ru1−N4 2.079(2) 2.091(2) 2.083(4) 2.071(4)
S1−O1 1.486(2) 1.489(2) 1.485(3) 1.501(6)
C1−Ru1−N2 157.92(8) 158.45(9) 158.5(2) 155.6(7)
N3−Ru1−N4 78.07(7) 78.67(7) 78.9(1) 78.2(1)
S1−Ru1−N4 96.25(5) 97.29(5) 96.6(1) 96.0(1)
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in [1]PF6 (2.2558(7) Å) than in [Ru(tpy)(bpy)(DMSO-
κS)]2+ (2.282(1) Å) as a result of the increased electron
density on ruthenium, leading to stronger backbonding into
the π* orbital of the S-bound DMSO ligand. Overall, this
electronic effect barely affects the angles between C1−Ru1−
N3 for [1]PF6 (158.67(12) Å) and N1−Ru1−N3 for
[Ru(tpy)(bpy)(DMSO-κS)]2+ (157.92(8) Å), confirming
their high structural similarity (Figure 2).
Thermal Stability. With compounds [1]PF6−[5]PF6 in
hand, we first attempted to obtain diastereomers by the
thermal reaction of several chiral ligands as shown in Scheme 2
and summarized in Table 2 (entries 1−6). Heating [1]PF6 and
(R)-methyl p-tolylsulfoxide at increased temperatures (up to
120 °C) in DMF resulted in the formation of ruthenium(III)
species, as observed by a green color, whereas lower
temperatures only led to the recovery of starting materials.
Further attempts to substitute the monodentate ligand with
nonchiral ligands (entries 7 and 8) such as LiCl, pyridine, or
acetonitrile also proved to be unsuccessful. This thermal
inertness was highly unexpected, since terpyridine analogues of
these complexes are known to readily exchange their
monodentate ligand in similar or much milder conditions.30
The only thermal substitution possible, observed with
[4](PF6)2, was obtained by prolonged heating (16 h) in acetic
acid, which resulted in the partial formation of [Ru(phbpy)-
(dppz)(AcOH)]+ as proven by mass spectrometry (found m/z
675.1, calcd. m/z 675.1). However, this species could not be
isolated. Overall, the exceptional thermal inertness of the
DMSO ligand in [1]PF6−[5]PF6 required the development of
an alternative strategy for the resolution of this family of chiral
complexes.
Photosubstitution. Replacing the DMSO ligands in these
complexes was therefore attempted photochemically, monitor-
ing the reaction using 1H NMR. When a sample of [2]PF6 was
irradiated in acetonitrile with white light (hν ≥ 410 nm,
Scheme 3), a clean photoconversion to a new species was
observed, which was confirmed to be the acetonitrile adduct by
mass spectrometry. As shown in Figure 3, the 1H NMR spectra
clearly demonstrate the formation of the single species
[Ru(phbpy)(phen)(MeCN)]+ ([7]+) characterized by a
doublet appearing at 9.88 ppm, while the doublet of the
starting material at 10.49 ppm quantitatively disappeared. This
photochemical behavior is comparable to the photosubstitu-
tion occurring in [Ru(tpy)(N−N)(X)]2+.31 In a similar
fashion, the DMSO ligand in [1]PF6 and [3]PF6 could also
be exchanged upon photoirradiation by deuterated acetonitrile
to afford [Ru(phbpy)(bpy)(CD3CN)]
+ ([6]+) and [Ru-
(phbpy)(dpq)(CD3CN)]
+ ([8]+), respectively. However,
[4]PF6 and [5]PF6 were not photosubstitutionally active, in
contrast to the noncyclometalated analogons [Ru(tpy)(dppz)-
(SRR′)] and [Ru(tpy)(dppn)(SRR′)] (SRR′ = 2-(2-(2-
(methylthio)ethoxy)ethoxy)ethyl-β-D-glucopyranoside)27 that
both exchange their thioether ligand upon light irradiation.27
Resolving Diastereomers. The photoactivity of [1]PF6−
[3]PF6 therefore allowed us to investigate separation of their
Figure 2. Displacement ellipsoid plots (50% probability level) of the cationic part of the crystal structure of [1]PF6 (a), [2]PF6 (b), [3]PF6 (c), and
[4]PF6 (d). Hydrogen atom and counterions have been omitted for clarity.
Scheme 2. General Approach for the Thermal Conversion of
Complexes [1]PF6, [2]PF6, and [4]PF6 with Different
Monodentate Ligands L
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enantiomers. [2]PF6 was used as representative example. In a
first attempt, [2]PF6 was converted to [7]PF6 using white light
irradiation in deuterated acetonitrile (∼7 h). However, neither
chiral HPLC nor crystallization using sodium (+)-tartrate
allowed for resolving this intermediate. Instead, an alternative
approach was used: racemic [7]PF6 was allowed to react with
an excess of enantiomerically pure (R)-methyl p-tolylsulfoxide
in MeOH, affording a (1:1) mixture of diastereomers of
(anticlockwise/clockwise) A/C-[Ru(phbpy)(phen)(R)-Meth-
yl p-tolylsulfoxide)]PF6, [11-A/C]HCO2 (Scheme 3). Sub-
Table 2. Attempts of Ligand Exchange for [1]PF6, [2]PF6, and [4]PF6
entry complex ligand (L) solvent T (°C) substitution reaction time (h)
1 [1]PF6 (R)-methyl p-tolylsulfoxide (5 equiv) DMF 120 16
2 [1]PF6 (R)-methyl p-tolylsulfoxide (5 equiv) DMF 80 16
3 [1]PF6 (R)-methyl p-tolylsulfoxide (5 equiv) EtOH 3:1 H2O 80 16
4 [4]PF6 biotin (20 equiv) EtOH 3:1 H2O 80 16
5 [4]PF6 N-acetyl-L-methionine (20 equiv) EtOH 3:1 H2O 80 16
6 [4]PF6 N-acetyl-L-cysteine methyl ester (20 equiv) EtOH 3:1 H2O 80 16
7 [4]PF6 L-histidine methyl ester 2HCl (20 equiv) EtOH 3:1 H2O 80 16
8 [2]PF6 LiCl (20 equiv) EtOH 3:1 H2O 80 16
9 [4]PF6 MeCN 80 16
10 [4]PF6 pyridine 80 16
11 [4]PF6 acetic acid 80 yes 16
Scheme 3. Reagents and Conditions for the Synthesis of [11-A/C]HCO2
a
a(a) hv ≥ 410 nm in CD3CN. (b) i. (R)-Methyl p-tolylsulfoxide in MeOH, reflux, 16 h; ii. Reverse-phase HPLC (0.1% HCO2H in MeCN/H2O).
(5% over two steps for [11-A]HCO2, 4% over two steps for [11-C]HCO2).
Figure 3. Evolution of the 1H NMR spectra of [2]PF6 in CD3CN (3.0 mg in 0.6 mL) upon irradiation with white light (>410 nm) from a 1000 W
xenon Arc lamp fitted with 400 nm cutoff filter 1 cm from the light source at T = 298 K. Spectra were taken every 1 h, with tirr = 7 h.
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sequent purification over a reverse phase HPLC column
afforded [11-A]HCO2 and [11-C]HCO2 as their respective
diastereomers in 9% yield (5% over two steps for [11-A]HCO2
and 4% over two steps for [11-C]HCO2 (Figure S6).
1H NMR
confirmed that fraction 1 corresponded to the R-C
diastereomer, which is most apparent because of its more
shielded α-proton of phen appearing at 10.64 ppm (Figure 4).
Fraction 2 contained the R-A diastereomer, with a doublet
appearing at 10.74 ppm (Figure 4). This deshielding effect on
the α-proton on phen is most likely attributed to the
interaction of the tolyl group with the bidentate ligand. This
assumption was supported by NOESY experiments (Figure
S8), which showed the absence of interaction between the
methyl of the sulfoxide and phen, whereas a weak interaction
was observed for [11-A]HCO2 (Figure S8). Both [11-
A]HCO2 and [11-C]PF6 are diastereomers and not
enantiomers, so that specific rotation would not give any
valuable information on their chirality. Circular dichroism
(CD) was used instead to demonstrate they are related to the
two enantiomers [2-A]+ and [2-C]+. The CD spectra of [11-
A]PF6 and [11-C]PF6 in MeCN (Figure 5) displayed
symmetrical curves typical for enantiomers, except in the
region below 250 nm where the contribution of the chiral (R)-
tolylsulfoxide ligand to the absorption becomes non-
negligible.32 Around 450 nm, either positive or negative
Cotton effects were observed for [11-A]PF6 or [11-C]PF6,
respectively, which must originate from the 1MLCT
transitions. Theoretically, resolution of these complexes by
performing blue light irradiation in acetonitrile may be
tempting. However, photosubstitution is usually accompanied
by racemization of the coordination sphere, so that thermal
ligand substitution would be preferred.33 This was however not
possible due to the exceptional thermal stability of the
sulfoxide cyclometalated complexes (see above) that prevented
thermal displacement of the chiral sulfoxide to obtain isolated
enantiomers of [A-7]+, [C-7]+, [A-2]+, or [C-2]+. However,
the mirrored CD spectra of the diastereoisomers [11-A]HCO2
and [11-C]HCO2 provided a clear proof of the opposite
chirality of these complexes.
Photophysical and Photochemical Characterization.
The difference in photoreactivity between [1]+−[3]+ and
[4]+−[5]+ was not straightforward to understand, and
therefore a full photophysical characterization of the five
complexes was carried out. The electronic absorption spectra
(Figure S1) of these complexes show that they have a
considerable bathochromic shift (∼40 nm, Table 3) and a
significant broadening of their 1MLCT band compared to
[9]2+ (411 nm, Table 3). [4]+ and [5]+ have additional
absorption bands around 370 and 410 nm, respectively. These
are most likely π−π* transitions arising from the dppz and
dppn ligand. The spectra of [6]+−[8]+ in acetonitrile also
showed a shift of the 1MLCT band of ∼50 nm compared to
[10]2+. This bathochromic shift is common for cyclometalated
ruthenium complexes12,34 and is mostly ascribed to an increase
in the energy of the highest occupied molecular orbital
(HOMO, t2g).
12
Visible light excitation of ruthenium polypyridyl complexes
typically leads to (1) ligand exchange, (2) phosphorescence
and/or, (3) singlet oxygen generation. First, the ability of
[1]PF6−[5]PF6 to exchange the DMSO ligand for a solvent
molecule was quantified by UV−vis spectroscopy (Figure 6).
As observed under white light irradiation (>450 nm),
monochromatic blue light irradiation in acetonitrile (450
nm) left [4]PF6 and [5]PF6 unaffected, while [1]PF6−[3]PF6
converted to the acetonitrile complexes [6]PF6−[8]PF6 with
clear isosbestic points (441 and 490 nm for [1]PF6, 470 nm for
[2]PF6, and 455 nm for [3]PF6) confirming the selectivity of
the photoconversion. ESI-MS spectra taken after each reaction
confirmed the formation of the acetonitrile photoproducts.
The photosubstitution quantum yields (Φ450) were found to
be 4.1 × 10−5 for [1]PF6, 1.3 × 10
−5 for [2]PF6, and 2.2 ×
10−5 for [3]PF6, which is a thousand times lower than that
measured for [Ru(tpy)(bpy)(DMSO-κS)]2+(Φ450 = 1.6 ×
10−2). This decreased reactivity is most likely caused by the
destabilization of the 3MC state due to increased electron
density at the metal center brought by the strong σ-donor C
atom, whereas stabilization of the 3MLCT leads to a larger
energy gap between the 3MLCT and 3MC state, therefore
making thermal population of the latter rather unlikely.34 This
interpretation is supported by previous work of the Turro
group, who has demonstrated that the efficiency of the
photosubstitution in sterically congested cyclometalated
complexes is very low or absent.12,22
Second, emission maxima (λem) and emission quantum
yields (ΦP) for [1]PF6−[5]PF6 were measured in acetonitrile
(Table 3). All compounds were found very weakly emissive
Figure 4. 1HNMR spectrum (850 MHz) of [11-C]PF6 (top) and [11-A]PF6 (bottom).
Figure 5. Superposition of CD spectra of first fraction (black, [11-
C]HCO2) and second fraction (red, [11-A]HCO2) eluted diaster-
eoisomers. T = 293 K, c = 5 × 10−5 M in MeCN.
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with a slightly higher phosphorescence quantum yield
compared to the polypyridyl complex [Ru(phbpy)(tpy)]+
(ΦP = 5 × 10−6).35 The emission wavelengths found for
[1]+−[3]+ are comparable to those of [Ru(phbpy)(tpy)]+
(786−800 nm versus 797 nm)35 and are similar to complexes
reported by the group of Turro and Sauvage.12,35 For
complexes [4]+ and [5]+ a blue-shifted emission (618 and
672 nm) was observed compared to [Ru(phbpy)(tpy)]+,
which suggested a different type of excited state compared to
[1]+−[3]+. Third, singlet oxygen quantum yields (ΦΔ) were
determined in deuterated methanol by measuring the emission
of 1O2 at 1270 nm. ΦΔ values lower than 0.04 were found for
all complexes with the exception of [3]PF6, which produced
1O2 with a photoefficiency (ΦΔ) of 0.11. Interestingly,
[Ru(phbpy)(dppn)(DMSO-κS)]+ did not show any singlet
oxygen production, whereas its noncyclometalated analogues
[Ru(tpy)(dppn)(CD3OD)]
2+ and [Ru(tpy)(dppn)(py)]2+
both have been demonstrated to be excellent 1O2 gener-
ators.36,37 Overall, changing terpyridine into phenylbipyridine
had great consequences on the photochemical and photo-
physical properties of this series of complexes. Therefore, to
further understand the photophysical differences between
complexes [1]+−[3]+and [4]+−[5]+ electrochemical studies
and DFT calculations were carried out.
Electrochemistry and DFT. The electrochemical proper-
ties of complexes [1]PF6−[7]PF6 and [9](PF6)2−[10](PF6)2
were determined with cyclic voltammetry (Figure 7 and Table
4) to provide insight into the frontier orbitals of the
cyclometalated complexes.38 As summarized in Table 4, the
cyclometalated DMSO complexes [1]PF6−[5]PF6 show quasi-
reversible oxidation processes (Ipa/Ipc ≈ 1) with RuIII/RuII
couples near ∼+0.30 V vs Fc0/+ whereas [9](PF6)2 showed an
Table 3. Lowest-Energy Absorption Maxima (λmax), Molar Absorption Coefficients at λmax (ε in M
−1 cm−1), Photosubstitution
Quantum Yields in Acetonitrile (Φ450) at 298 K, 1O2 Quantum Yields (ΦΔ) at 293 K, and Phosphorescence Quantum Yield
(ΦP) for [1]PF6−[10](PF6)2
complex formula λmax (εmax in M
−1 cm−1)a λem (nm) ΦΔb ΦPb Φ450
[1]PF6 [Ru(phbpy)(bpy)(DMSO-κS)]PF6 476 (50 × 102) 786 3.2 × 10−2 1.6 × 10−4 4.1 × 10−5
[2]PF6 [Ru(phbpy)(phen)(DMSO-κS)]PF6 450 (57 × 102) 800 3.9 × 10−2 2.1 × 10−4 1.3 × 10−5
[3]PF6 [Ru(phbpy)(dpq)(DMSO-κS)]PF6 451 (83 × 102) 787 1.1 × 10−1 2.1 × 10−4 2.2 × 10−5
[4]PF6 [Ru(phbpy)(dppz)(DMSO-κS)]PF6 450 (84 × 102) 618 7.0 × 10−3 2.6 × 10−4 <10−6
[5]PF6 [Ru(phbpy)(dppn)(DMSO-κS)]PF6 450 (75 × 102) 672 <10−3 8.4 × 10−5 <10−6
[6]PF6 [Ru(phbpy)(bpy)(CD3CN)]PF6 525 (71 × 102) n.d. n.d. n.d.
[7]PF6 [Ru(phbpy)(phen)(CD3CN)]PF6 503 (63 × 102) n.d. n.d. n.d.
[8]PF6 [Ru(phbpy)(dpq)(CD3CN)]PF6 495 (119 × 10
2) n.d. n.d. n.d.
[9](PF6)2 [Ru(tpy)(bpy)(DMSO-κS)](PF6)2 411 (75 × 10
2) n.d. n.d. n.d. 1.6 × 10−2
[10](PF6)2 [Ru(tpy)(bpy)(MeCN)](PF6)2 455 (91 × 10
2) n.d. n.d. n.d.
aIn MeCN. bin CD3OD.
Figure 6. Time evolution of the electronic absorption spectra of [1]PF6−[3]PF6 and [9](PF6)2 in deoxygenated MeCN upon irradiation at 450 nm
at T = 298 K. Spectra measured every 30 min (every 0.5 min for [9]PF6). (a) [1](PF6) tirr = 16 h, [Ru]tot = 5.78 × 10
−5 M, photon flux = 1.68 ×
10−7 mol s−1. (b) [2](PF6), tirr = 23 h, [Ru]tot = 6.08 × 10−5 M, photon flux = 1.67 × 10−7 mol s−1. (c) [3]PF6, tirr = 16 h, [Ru]tot = 4.06 × 10−5 M,
photon flux = 1.68 × 10−7 mol s−1. (d) [9](PF6)2, tirr = 1 h, [Ru]tot = 6.52 × 10
−5 M, photon flux = 5.54 × 10−8 mol s−1.
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irreversible RuII → RuIII oxidation at +1.23 V vs Fc0/+.
Although the irreversibility of the oxidation of [9](PF6)2 does
not strictly speaking allow to analyze this oxidation potential to
a HOMO energy level, for [1]PF6−[5]PF6 the low-lying,
reversible oxidation suggests that the Ru(dπ)-based HOMO of
the cyclometalated complexes is very high in energy, due to the
π-donating character of the phbpy− ligand.12 As the
irreversibility of the oxidation of [9](PF6)2 is attributed to
linkage isomerization of DMSO from S-bound to O-bound,39
cyclometalation also appears to prevents redox-induced linkage
isomerization of the DMSO ligand, most likely due to the
increased electron density on ruthenium. The quasi-reversible
RuIII/II couple of the DMSO complexes [1]PF6−[2]PF6 also
appeared at a higher potential (+0.30 V vs Fc0/+) compared to
that of the acetonitrile compounds [6]PF6−[7]PF6 (0.00 V vs
Fc0/+), which can be explained by the electronic effects of the
monodentate ligand; κS-DMSO is a stronger π-acceptor than
CD3CN and therefore has a stronger electron withdrawing
effect on ruthenium(II).40 The ligand-based reductions for
[1]PF6−[3]PF6 was found to have very similar energies, with
quasi-reversible reductions around −2.0 V vs Fc+/0, suggesting
that these are phbpy-based. For [4]PF6 and [5]PF6 however
the L0/‑ appeared to occur at much less negative potentials
(−1.4 V vs Fc+/0 for [4]PF6 and −1.2 V vs Fc+/0 for [5]PF6)
due to the strong electron-accepting properties of the
dipyridophenazine moieties. These first reductions being
essentially reversible, the LUMO of these two complexes is
dppz- or dppn-based, respectively.41 The experimental HOMO
− LUMO gaps ΔEexp, which can be approximated, for quasi-
reversible redox couples, to the difference between Eox and Ered
(Figure 7, left), followed similar trends to the theoretical
HOMO − LUMO gaps ΔEth calculated by DFT (Table 4).
ΔEth were found very comparable indeed for complexes
[1]PF6−[3]PF6 (ΔEexp ≈ 2.2 V and ΔEth ≈ 3.6 V) and much
higher than that of [4]PF6 and [5]PF6 (ΔEexp = 1.8 and 1.6 V,
respectively, and ΔEth = 3.13 and 1.86 V). The particularly low
value of ΔE found for [4]PF6 and [5]PF6 suggested that the
dppz and dppn ligands may generate low-lying excited states,
which would explain the absence of photosubstitution with
these two complexes.
To confirm this hypothesis, density functional theory (DFT)
calculations were performed for [1]+−[5]+ at the PBE0/TZP/
COSMO level. The calculated HOMO energy, LUMO energy,
and ΔEth = ELUMO − EHOMO of the minimized geometries
followed the same trend as the experimental values (Table 4
and Figure 7b). For [1]+ and [2]+ the LUMO was located on
Figure 7. (a) Cyclic voltammograms of cyclometalated complexes [1]PF6−[7]PF6 and noncyclometalated complexes [9](PF6)2 and [10](PF6)2.
Scan rate 100 mV s−1, with the exception of [4]PF6, [6]PF6, [7]PF6, and [9]PF6 which were measured at 200 mV s
−1. L = DMSO-κS or CD3CN.
(b) Experimental (Eox and Ered from cyclic voltammetry, in V vs. Fc
+/0, left axis) and calculated (from DFT, in eV, right axis) values of the HOMO
energy, LUMO energy, and ΔE energy gap.
Table 4. Electrochemical Properties As Measured with Cyclic Voltammetry and Theoretical HOMO − LUMO Gaps
Calculated by DFTa
Eox (V) Ipa/Ipc Ered (V) Ipc/Ipa ΔEexp (V)c ΔEth (eV)d
[Ru(phbpy)(bpy)(DMSO-κS)]PF6 [1]PF6 +0.30 0.99 −1.90 1.47 2.20 3.65
[Ru(phbpy)(phen)(DMSO-κS)]PF6 [2]PF6 +0.32 1.02 −1.89 1.11 2.21 3.65
[Ru(phbpy)(dpq)(DMSO-κS)]PF6 [3]PF6 +0.29 1.01 −1.87, −1.95 0.66, 2.23 2.16 3.57
[Ru(phbpy)(dppz)(DMSO-κS)]PF6 [4]PF6 +0.35 1.04 −1.43, −2.00 1.03 1.78 3.13
[Ru(phbpy)(dppn)(DMSO-κS)]PF6 [5]PF6 +0.36 1.05 −1.21, −1.82, −2.01 1.07, 1.52 1.57 2.86
[Ru(phbpy)(bpy)(CD3CN)]PF6 [6]PF6 0.00 1.00 −2.05 1.34 2.05
[Ru(phbpy)(phen)(CD3CN)]PF6 [7]PF6 +0.02 1.04 −2.05 1.38 2.07
[Ru(tpy)(bpy)(DMSO)](PF6)2 [9](PF6)2 +1.23
b −1.48 1.00 2.71
[Ru(tpy)(bpy)(MeCN)](PF6)2 [10](PF6)2 +0.92 0.95 −1.67 1.06 2.59 4.12
aPotentials given vs. Fc0/Fc+ in MeCN with 0.1 M [Bu4N]PF6 as supporting electrolyte. Complexes were measured at 298 K with a scan rate of 100
mV s−1, with the exception of [4]PF6, [6]PF6 [7]PF6, and [9]PF6 which were measured at 200 mV s
−1. bEpa.
cΔEth = ELUMO − EHOMO at the DFT/
PBE0/TZP/COSMO level in water. dΔEexp = Eox − Ered,.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.8b10264
J. Am. Chem. Soc. 2019, 141, 352−362
358
the phbpy− ligand, for [4]+ and [5]+ it was localized on the
dppz and dppn bidentate ligand, respectively (Figure S3−5),
whereas for [3]+ empty orbitals localized both on phbpy− and
dpq were found close in energy and near the LUMO level.
Thus, like for the terpyridine series,41 extending the
conjugation of the bidentate ligand in the cyclometalated
series [1]+ to [5]+ resulted in a strong stabilization of the
LUMO in [4]+ and [5]+, and in a shift of its localization, from
the tridentate ligand in [1]+ and [2]+ to the bidentate ligand in
[4]+ and [5]+, with [3]+ as borderline species (Figure 7b). The
strong stabilization of the LUMO in [4]+ and [5]+ generates
low-lying excited states, most likely of 3π−π* character.
Discussion. Recent examples of the group of Turro have
shown that complexes such as cis-[Ru(phpy)(phen)-
(CH3CN)2]PF6 are as photoactive as their noncyclometalated
counterparts, with a reported photosubstitution quantum yield
(ΦP) of 0.25 in dichloromethane.22 A more recent report by
Albani et al. has shown that for [Ru(biq)2(phpy)]PF6 the
phpy− ligand increases the energy of the 3MC state, which in
their case completely prevents photodissociation of the
bidentate biq ligand.12 In the family of complexes [1]+−[5]+
presented here (Figure 8), cyclometalation of the terpyridine
ligand allows photoinduced ligand exchange for three of the
five complexes ([1]+−[3]+), while it is absent in the more
conjugated analogues [4]+ and [5]+. The photoreactivity of
ruthenium complexes is result of a delicate interplay of excited
states of different natures and energies. In [1]+, [2]+, and [3]+
the emission maximum was close to 800 nm, irrespective of the
nature of the bidentate ligand, because the 3MLCT excited
states must be located on the phbpy ligand. By contrast, in the
more conjugated complexes [4]+ and [5]+ the emission
maxima depend significantly on the bidentate ligand, with a
higher energy (λem = 618 nm) for the less conjugated dppz
complex, compared to dppn (λem = 672 nm, see Table 3). Two
results are apparently contradictory: the higher energy of the
emitting (3MLCT) excited states vs the very low calculated
and experimental ΔE values in [4]+ and [5]+, compared to
[1]+, [2]+, and [3]+. This contradiction suggests that the lower
triplet states centered on dppz and dppn and arising from the
photochemical population of the low-lying LUMO-like orbitals
are not emissive; they are probably of 3π−π* character and
centered on the phenazine moiety of the dppz or dppn ligand.
The weakly emissive states, on the other hand, most likely of
3MLCT character, are higher in energy in [4]+ and [5]+
because they are centered on the bpy moiety of dppz or
dppn, while in [1]+, [2]+, and [3]+ they are centered on the
more conjugated phenyl-functionalized bipyridine ligand. All in
all, the ligand photosubstitution reactions occur from metal-
centered 3MC states, which are high in energy for [1]+−[5]+
due to the excellent σ-donor properties of the cyclometalated
ligand and probably poorly dependent on the conjugation of
the bidentate ligand. Due to the presence of their low-lying
3π−π* states, [4]+ and [5]+ cannot perform any photo-
substitution, as nonradiative decay pathways are faster.42 For
[1]+, [2]+, and [3]+ these 3π−π* states are much higher in
energy, so that the photogenerated, low-lying phbpy-based
3MLCT states, in spite of the higher-lying 3MC states, still
leads to photosubstitution, though at a significantly lower rate
than in the terpyridine analogue [9]2+.
Chiral-at-metal complexes based upon ruthenium, iridium,
or rhodium have been extensively investigated by the group of
Meggers,43−45 Barton,46 and others47−49 and have shown great
promise in, e.g., asymmetric (photo)catalysis50,51 or as
anticancer drugs.52 To resolve these types of complexes, a
classical method consists of coordinating an enantiomerically
pure chiral auxiliary to the metal center, resulting in a mixture
of diastereomers which can be separated in preparative scales
using normal phase chromatography such as silica.53 After
separation, these diastereoisomers are typically treated with an
achiral monodentate ligand of interest, thus resolving the two
pure enantiomers. Other resolution methods involve direct
recrystallization of enantiomers using chiral counterions such
Figure 8. LUMO orbitals for [Ru(tpy)(bpy)L]2+ ([9]2+) and for [1]+−[5]+ at the DFT/PBE0/TZP/COSMO level in water.
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as Δ-TRISPHAT,32,54−56 or separation of the enantiomers on
chiral HPLC.46 For [1]+−[5]+ these strategies could not be
followed due on the one hand to the exceptional inertness of
the coordination sphere and possibly to the very similar
molecular shape of the cyclometalated vs. pyridyl side of the
ruthenium-coordinated phbpy ligand. We hence relied on
photochemical substitution to introduce a chiral sulfoxide
ligand as resolving agent. The resulting diastereoisomeric
ruthenium complexes [11-A]PF6 and [11-C]PF6 were
inseparable on normal-phase silica. We therefore diverted to
the use of reverse phase HPLC using 0.1% formic acid in the
eluent. As a result, the isolation of the two diastereoisomers as
their formate complexes was possible, but the presence of
formic acid affected the overall yield (9%), most likely due to
partial reprotonation of the cyclometalated ligand and
subsequent (partial) degradation of the products. This is an
issue that will be addressed in the future.
■ CONCLUSION
Replacing the terpyridine tridentate ligand in [Ru(tpy)(NN)-
L]2+ with phbpy has led to a new family of chiral-at-metal
complexes [1]+−[5]+ with drastically altered thermal and
photochemical properties compared to their polypyridine
analogues. In particular, thermal substitution of the mono-
dentate sulfoxide ligands becomes virtually impossible, while
the ligand photosubstitution efficiency was reduced or even
quenched due to the strong effect of cyclometalation on the
energy of the HOMO and LUMO of the complexes. When
N−N is a phenazine-based ligand ([4]+ or [5]+), the LUMO is
based on the bidentate ligand and full quenching of the
photoreactivity occurred, in great contrast to the photo-
chemical behavior of terpyridine analogues such as [Ru(tpy)-
(dppz)(SRR’)]2+ or [Ru(tpy)(dppn)(SRR’)]2+ that undergo
selective photosubstitution in water (Φ450 = 0.0227 and
0.00095,36 respectively). The resolution of photosubstitution-
ally and thermally inert chiral cyclometalated complexes such
as [4]+ and [5]+ will thus require strategies that still need to be
developed. However, when N−N is bpy, phen, or dpq ([1]+−
[3]+), selective photosubstitution of DMSO by acetonitrile
remained possible. The ability of [1]+−[3]+ to exchange
DMSO by acetonitrile upon visible light irradiation can be
exploited, as demonstrated here with [2]+, to labilize the
thermally inert achiral DMSO ligand and replace it in two steps
by a chiral sulfoxide ligand, thus allowing the separation of the
two chiral isomers [11-A]+ and [11-C]+. This works
demonstrates that photosubstitution reactions can be useful
for the resolution of chiral-at-metal organometallic complexes,
which opens new synthetic routes toward catalytically or
biologically active chiral organometallic complexes.
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